These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3130898)

  • 1. [Purification and characteristics of a protective factor from Bacillus anthracis toxin].
    Abalakin VA; Sergeeva LV; Cherkasova TD
    Biokhimiia; 1988 Feb; 53(2):283-8. PubMed ID: 3130898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The isolation and purification of the protective antigen and the edema factor from the culture filtrate of Bacillus anthracis STI-1].
    Rogov SN; Beznosov MV; Chugaĭ VL; Bashkova VA
    Med Parazitol (Mosk); 1995; (4):35-8. PubMed ID: 8587516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of gel chromatography for the isolation of biologically active toxin complex from Bacillus anthrax].
    Tafel'shteĭn EE; Markov EIu; Blinova LS; Kondrat'eva AM; Bashkova VA
    Mol Gen Mikrobiol Virusol; 1985 Dec; (12):39-42. PubMed ID: 3939572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of the functionally active domains in the molecule of protective antigen of the anthrax exotoxin].
    Noskov AN; Kravchenko TB; Noskova VP
    Mol Gen Mikrobiol Virusol; 1996; (3):16-20. PubMed ID: 8999312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective and other biological properties of Bacillus anthracis soluble antigens.
    Abalakin VA; Cherkasova TD; Sergeeva LV; Cherkassky BL
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(1):83-95. PubMed ID: 1908875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Western blot analysis of the exotoxin components from Bacillus anthracis separated by isoelectric focusing gel electrophoresis.
    Little SF
    Biochem Biophys Res Commun; 2004 Apr; 317(1):294-300. PubMed ID: 15047182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of the functionally active domains in the molecule of the lethal factor of the anthrax exotoxin].
    Noskov AN; Kravchenko TB; Noskova VP
    Mol Gen Mikrobiol Virusol; 1996; (3):20-2. PubMed ID: 8999313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis.
    Rhie GE; Park YM; Han JS; Yu JY; Seong WK; Oh HB
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):341-7. PubMed ID: 16019195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the lethal Bacillus anthracis toxin on phagocytosis and the dynamics of the change in the enzyme activity of the antioxidative system of peritoneal mononuclear phagocytes in mice with differing hereditary immunity to anthrax].
    Abalakin VA; Sorochinskaia EP; Osipova NI; Iurkiv VA
    Biull Eksp Biol Med; 1989 Mar; 107(3):288-91. PubMed ID: 2496765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of bacterial exotoxins. The case of botulinum, tetanus, anthrax, pertussis and cholera toxins.
    Pasechnik VA; Shone CC; Hambleton P
    Bioseparation; 1992-1993; 3(5):267-83. PubMed ID: 1369426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis.
    Rhie GE; Park YM; Chun JH; Yoo CK; Seong WK; Oh HB
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):331-9. PubMed ID: 16009541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized production and purification of Bacillus anthracis lethal factor.
    Park S; Leppla SH
    Protein Expr Purif; 2000 Apr; 18(3):293-302. PubMed ID: 10733882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis.
    Ramirez DM; Leppla SH; Schneerson R; Shiloach J
    J Ind Microbiol Biotechnol; 2002 Apr; 28(4):232-8. PubMed ID: 11986925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of three exotoxic factors of Bacillus anthracis by sequential immunosorbent chromatography.
    Larson DK; Calton GJ; Little SF; Leppla SH; Burnett JW
    Toxicon; 1988; 26(10):913-21. PubMed ID: 3144059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of anthrax toxin protective antigen from Escherichia coli.
    Sharma M; Swain PK; Chopra AP; Chaudhary VK; Singh Y
    Protein Expr Purif; 1996 Feb; 7(1):33-8. PubMed ID: 9172780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable purification of Bacillus anthracis protective antigen from Escherichia coli.
    Gwinn W; Zhang M; Mon S; Sampey D; Zukauskas D; Kassebaum C; Zmuda JF; Tsai A; Laird MW
    Protein Expr Purif; 2006 Jan; 45(1):30-6. PubMed ID: 15935696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.